3
Clinical Trials associated with Anti-BCMA CAR-T (Beijing Gaobo Boren Hospital )A phase II clinical study of BCMA-CART in the treatment of relapsed and refractory multiple myeloma
Fully human BCMA CAR T cells from related donors combined with allogeneic hematopoietic stem cells: single-center, open, non-randomized, single-arm clinical trial of transplantation for refractory/relapsed multiple myeloma
Clinical study of autologous mouse-derived BCMA-CART in the treatment of relapsed and refractory multiple myeloma
100 Clinical Results associated with Anti-BCMA CAR-T (Beijing Gaobo Boren Hospital )
100 Translational Medicine associated with Anti-BCMA CAR-T (Beijing Gaobo Boren Hospital )
100 Patents (Medical) associated with Anti-BCMA CAR-T (Beijing Gaobo Boren Hospital )
100 Deals associated with Anti-BCMA CAR-T (Beijing Gaobo Boren Hospital )